Meeting
2011 ASCO Annual Meeting
Large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays.
Authors
T. Li
University of California, Davis, Sacramento, CA
T. Li , P. C. Mack , S. Desai , K. Kelly , J. Cooc , P. V. Danenberg , K. D. Danenberg , D. R. Gandara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Staging
Citation
J Clin Oncol 29: 2011 (suppl; abstr 10520)
Abstract #
10520
Poster Bd #
12
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Update on the large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays.
First Author: Tianhong Li
Poster
2020 ASCO Virtual Scientific Program
Correlation of baseline molecular and clinical variables with ALK inhibitor efficacy in ALTA-1L.
First Author: D. Ross Camidge
Poster
2018 ASCO Annual Meeting
An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients.
First Author: Laura Mezquita
Poster
2024 ASCO Breakthrough
Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.
First Author: Sofia Diana Merajver